Lotter H, Mannweiler E, Schreiber M, Tannich E
Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
J Clin Microbiol. 1992 Dec;30(12):3163-7. doi: 10.1128/jcm.30.12.3163-3167.1992.
A recombinantly expressed protein, recEh-P1, representing part of an immunodominant surface antigen of pathogenic Entamoeba histolytica, was used for serodiagnosis of invasive amebiasis. Expression was performed under the control of a T7-RNA promoter by using a modified procaryotic expression vector, designated pHisT7. This vector allowed high-yield expression of recEh-P1 fused to a stretch of sequence containing eight histidine residues, which facilitated purification by metal chelate affinity chromatography on Ni2+ columns under highly denatured conditions. Purified recEh-P1 was found to be water soluble after prolonged dialysis and was used as the antigen for the detection of antiamebic serum antibodies by immunoblotting and enzyme-linked immunosorbent assay. In both tests all sera of patients with invasive amebiasis reacted to recEh-P1 whereas none of those collected from healthy controls, including individuals with noninvasive amebiasis, or from patients suffering from bacterial or protozoan infections unrelated to E. histolytica did so.
一种重组表达的蛋白recEh-P1,它代表致病性溶组织内阿米巴免疫显性表面抗原的一部分,被用于侵袭性阿米巴病的血清学诊断。通过使用一种改良的原核表达载体(命名为pHisT7),在T7-RNA启动子的控制下进行表达。该载体能够使recEh-P1与一段含有八个组氨酸残基的序列融合后实现高产表达,这有助于在高度变性条件下通过Ni2+柱上的金属螯合亲和层析进行纯化。经长时间透析后发现纯化的recEh-P1是水溶性的,并被用作抗原,通过免疫印迹和酶联免疫吸附测定来检测抗阿米巴血清抗体。在这两种检测中,所有侵袭性阿米巴病患者的血清都与recEh-P1发生反应,而从健康对照者(包括非侵袭性阿米巴病患者)或患有与溶组织内阿米巴无关的细菌或原生动物感染的患者中采集的血清均未出现这种反应。